Related Experiment Video
Updated: Feb 1, 2026

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
Published on: July 4, 2007
IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
Birgit Maria Köhler1, Hanns-Martin Lorenz1, Norbert Blank1
1Division of Rheumatology, Department of Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Objective:
Approximately 10%-20% of patients with familial Mediterranean fever (FMF) show an inadequate response to colchicine. In our cohort study, patients with FMF with or without amyloidosis and with an inadequate response to colchicine were treated with anakinra or canakinumab.
Methods:
Clinical and laboratory parameters, Mediterranean fever (MEFV) mutations, and patient-reported outcomes were analyzed in 31 patients treated with anakinra or canakinumab.
Results:
In a cohort of 250 adult patients with FMF, 31 patients were treated with anakinra (n=29) or canakinumab (n=2). The median Pras FMF severity score was 8 (range, 5-14) and correlated with the presence of high-penetrance MEFV mutations (p.Met-694-Val or p.Met-680-Ile). The FMF severity score was 11 in patients with two high-penetrance MEFV mutations (68%), 9 in those with a single high-penetrance MEFV mutation (19%), and 7.5 in those without high-penetrance MEFV mutations (13%, p=0.2). FMF-related amyloid A amyloidosis was diagnosed in 12 (39%) patients. Anakinra was used daily in 20 patients, thrice a week in 7, and upon demand during attacks in 2. Two patients were treated with canakinumab. IL-1-blocking treatment showed a rapid (2±3 days) and persistent suppression of FMF symptoms and inflammatory parameters. The frequency of FMF attacks was significantly reduced (p<0.003). Both patient- and physician-reported FMF activity significantly improved (p<0.0001).
Conclusion:
IL-1-blocking therapy was well tolerated over a median period of 2 years and reduced the frequency of FMF attacks in patients with colchicine-resistant FMF.
Insights
Interleukin-1 (IL-1) blocking therapy effectively reduced familial Mediterranean fever (FMF) attacks in patients resistant to colchicine. This treatment demonstrated rapid symptom suppression and was well-tolerated long-term.
Area of Science:
- Rheumatology
- Genetics
- Immunology
Background:
- Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
- Colchicine resistance affects 10%-20% of FMF patients, necessitating alternative treatments.
- FMF can lead to severe complications like amyloidosis.
Purpose of the Study:
- To evaluate the efficacy and safety of IL-1 blocking agents (anakinra or canakinumab) in FMF patients with inadequate response to colchicine.
- To assess the impact of IL-1 blockade on FMF disease activity, severity scores, and patient-reported outcomes.
Main Methods:
- A cohort study analyzing 31 adult FMF patients with colchicine resistance.
- Patients were treated with anakinra or canakinumab.
- Clinical, laboratory, MEFV mutation data, and patient-reported outcomes were collected and analyzed.
Main Results:
- IL-1 blocking therapy rapidly suppressed FMF symptoms and inflammation within 2±3 days.
- Significant reduction in FMF attack frequency (p<0.003) and improved FMF activity (p<0.0001) were observed.
- FMF severity correlated with high-penetrance MEFV mutations; 39% of patients had amyloidosis.
Conclusions:
- IL-1 blocking therapy is a well-tolerated and effective treatment for colchicine-resistant FMF.
- Therapy provides sustained suppression of FMF symptoms and reduces attack frequency.
- Long-term treatment (median 2 years) showed good tolerability.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
21:55Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Related Concept Videos
Family Therapy
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Types of Fever
Here are the different types of fever: